Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel
· Delayed Price · Currency is ILS · Price in ILA 839.20
-1.30 (-0.15%)
Apr 24, 2025, 5:24 PM IDT
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of 340.59 million as of April 24, 2025. Its market cap has decreased by -17.59% in one year.
Market Cap
340.59M
Enterprise Value
-175.88M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
839.20
Market Cap Chart
Since March 19, 2004, Oramed Pharmaceuticals's market cap has increased from 2.37M to 340.59M, an increase of 14,262.89%. That is a compound annual growth rate of 26.53%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 59.80B |
| Danel (Adir Yeoshua) | 2.34B |
| Kamada | 1.38B |
| Bait Bakfar | 933.61M |
| Novolog (Pharm-Up 1966) | 812.75M |
| Ilex Medical | 703.35M |
| BrainsWay | 623.44M |
| SofWave Medical | 554.17M |